Compare THRM & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | THRM | OPK |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 844.7M | 921.2M |
| IPO Year | 1996 | 2011 |
| Metric | THRM | OPK |
|---|---|---|
| Price | $31.53 | $1.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $37.20 | $1.60 |
| AVG Volume (30 Days) | 233.4K | ★ 2.1M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | $554,979,000.00 | ★ $606,879,000.00 |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $7.12 | $4.24 |
| P/E Ratio | $219.93 | ★ N/A |
| Revenue Growth | ★ 50.16 | N/A |
| 52 Week Low | $26.68 | $0.98 |
| 52 Week High | $39.48 | $1.60 |
| Indicator | THRM | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 64.22 | 43.67 |
| Support Level | $30.58 | $1.12 |
| Resistance Level | $32.25 | $1.25 |
| Average True Range (ATR) | 1.14 | 0.04 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 80.73 | 55.85 |
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.